期刊文献+

乳腺导管内癌的腋窝淋巴结转移率与术式选择 被引量:5

The incidence of axillary metastases and appropriate surgery for ductal carcinoma in situ of the breast
下载PDF
导出
摘要 目的 :从腋窝淋巴结转移率的角度 ,探讨对乳腺导管内癌 (DCIS)的合理治疗方法。方法 :我院 1994年1月~ 2 0 0 3年 12月间收治的 16例女性DCIS患者 ,中位年龄 4 3岁 (30~ 84岁 ) ,中位随访时间 6 2 (6~ 114 )个月 ,2例作Halsted根治术 ,11例作改良根治术 ,2例作全乳切除术 ,1例作象限切除 +腋窝淋巴结清扫 ,术后 8例作辅助化疗 ,3例作放疗 ,10例作内分泌治疗。结果 :16例DCIS中 ,2例腋窝淋巴结有微转移。术后随访无复发 ,无死亡 ,只有 1例术后 4年骨扫描发现有髋转移。结论 :治疗DCIS宜行肿块扩大切除 (保乳手术 ) Purpose:To study the appropriate surgical treatment for ductal carcinoma in situ of the breast ( DCIS ).Methods:16 patients with DCIS treated between Jan 1994 and Dec 2003 were evaluated. All patients underwent lumpectomy and intraoperative frozen section evaluation. The median age was 43 years ( range 30 to 84 ) and the median pathologic size of DCIS was 2.0cm ( range 0.3 to 4cm ). 2 of these 16 patients had Halsted radical mastectomy, 11 had modified radical mastectomy, 2 had simple mastectomy and 1 had breast-conserving surgery ( quadrant excision plus axillary lymph node dissection ). As postoperative treatment, 3 patients received radiotherapy, 8 received chemotherapy and 10 had endocrine therapy.Results:2 patients were found to have axillary micrometastases. The median follow-up time was 62(6~114)months. All patients survived without recurrence. Only one patient was found to have metastasis in hipbone 4 years after operation.Conclusions:Lumpectomy or wider excision plus postoperative radiotherapy is feasible for most patients with DCIS.[
出处 《中国癌症杂志》 CAS CSCD 2004年第5期472-473,共2页 China Oncology
关键词 乳腺导管内癌 腋窝淋巴结转移 保乳手术 放疗 ductal carcinoma in situ axillary metastases breast conserving surgery radiotherapy
  • 相关文献

参考文献11

  • 1张亚伟 沈坤炜 等.乳腺导管内癌52例分析[J].中华肿瘤杂志,1999,21(5):391-391.
  • 2Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17[J].J Clin Oncol, 1998,16(2):441-452.
  • 3Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? [J].Ann Surg Oncol, 2000,7(9): 636-642.
  • 4Schwartz GF, Solin LJ, Olivotto IA, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999[J].Cancer, 2000,88(4):946-954.
  • 5Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast[J].Am J Surg, 2003,186(4):337-343.
  • 6Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma[J].World J Surg, 2001,25(6):767-772.
  • 7Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients[J].Ann Surg Oncol, 2000,7(1):15-20.
  • 8Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? [J].Am Surg, 2001,67(6):513-521.
  • 9Kelly TA, Kim JA, Patrik R, et al. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ[J].Am J Surg, 2003,186(4):368-370.
  • 10Intra M, Vernonesi P, Mazzarol G, et al. Axillary lymph node biopsy in patients with pure ductal carcinoma in situ of the breast[J].Arch Surg, 2003,138(3):309-313.

二级参考文献8

  • 1李树玲.乳腺肿瘤防治研究进展概况[A].李树玲主编.乳腺肿瘤学[C].北京:科学技术出版社,2000.3—8.
  • 2方志沂.乳腺癌临床诊断[A].李树玲主编.乳腺肿瘤学[C].北京:科学技术出版社,2000.381—390.
  • 3傅西林 刘复生 刘彤华主编.乳腺癌[A].刘复生,刘彤华主编.肿瘤病理学[C].北京:北京医科大学中国协和医科大学联合出版社,1997.1627—1633.
  • 4Winchester DP, Strom EA. Standards for diagnosis and management of DCIS of the breast [J] . CA - Cancer J Clin,1998, 48(2) : 108.
  • 5Silverstein MJ. Fortnightly review: DCIS of the breast[J] .Brit Med J, 1998, 317(7160) :734.
  • 6Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected DCIS treated with conservative surgery with or without radiation therapy: patterns of failure and 10- year results[J]. Ann Surg, 2000, 231(2) : 235.
  • 7Bellamy CO, Mcdonald C, Salter DM, et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categoriazation[J]. Hum Pathol, 1993, 24:16.
  • 8于泳,傅西林,方志沂,牛昀,范宇,吕阿娟,王颖.乳腺导管内癌全乳腺切片病理组织学及免疫组化研究[J].中国肿瘤临床,2001,28(5):354-357. 被引量:4

共引文献17

同被引文献37

  • 1李文萍,王颀,张安秦,许娟,赖日权,张江宇,陈中杨,杨剑敏.乳腺导管内癌及伴微浸润的病理和临床特征[J].中华普通外科杂志,2005,20(4):235-237. 被引量:21
  • 2李程.乳腺导管内癌的诊治进展[J].临床外科杂志,2005,13(5):319-320. 被引量:2
  • 3Jansen S A. Ductal carcinoma in situ: detection, diagno- sis, and characterization with magnetic resonance imaging [ J ]. Seminars Ultrasound,2011,32 (4) :306 - 318.
  • 4陈杰.病理学[M].北京:人民卫生出版社,2010.
  • 5Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients[J]. Ann Surg Oncol, 2000, 7(1) : 15-20.
  • 6Kordek R. Ductal carcinoma in situ-like structures in metastatic breast carcinoma [ J ]. Pathol Res Pract, 2005, 200(11-12) : 831-834.
  • 7Tada K, Ogiya A, Kimura K, et al. Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer [J]. World J Surg Oncol,2010,8(1) :6.
  • 8Silver S A,Tavassoli F A. Mammary ductal carcinoma in situ with microinvasion [ J ]. Cancer, 1998,82 ( 12 ) : 2 382-2 390.
  • 9Zujewski J, Eng-Wong j. Sentinel lymph node biopsy in the management of ductal carcinoma in situ [ J ]. Clin Breast Cancer,2005,6 ( 3 ) : 216 -222.
  • 10Ansari B, Ogston S A, Purdie C A, et al. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast[ J]. Br J Surg,2008,95 (5) :547-554.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部